TCL Archive Clearinghouse Subgroup Okeys Carcinogenesis Testing for Anticancer Drugs September 8, 1978
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Changes In Key Subcommittee chairmanships, Brooke’s Defeat Leave Direction In Doubt November 17, 1978
